DUR-928 30 mg
Sponsors
Durect
Conditions
Alcoholic Hepatitis
Phase 2
A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis
CompletedNCT03432260
Start: 2018-04-18End: 2019-09-09Updated: 2024-09-24
A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment
CompletedNCT04563026
Start: 2021-01-22End: 2023-09-06Updated: 2024-09-05